Lantern Pharma
Latest round
- Series A
Last raised
- May 2017
Total raised
- $4.7M
Investors
- 2
About Lantern Pharma
Based in Texas, US, and founded in 2013 Lantern Pharma, Inc. is a biotechnology company that provides oncology therapeutics using artificial intelligence, genomics, and machine learning to identify and developed cancer therapies. The company becomes a publicly listed company on the NASDAQ stock exchange, In June 2020. The company has approximately 18 employees. Lantern Pharma, Inc. is a biotechnology company. It is focused on leveraging artificial intelligence machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from targeted oncology therapies. The firm's pipeline of development programs involves three small molecule drug candidates namely LP-100, LP-184, and LP-300. The company generates revenue by offering the developed therapies to pharmaceutical companies. The company’s long-term objective is to identify more oncology-specific preclinical points towards the development of the RADR platform.
Who invested in Lantern Pharma
2 investors across 2 rounds
See all investors in Lantern Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lantern Pharma
Who invested in Lantern Pharma?
Lantern Pharma has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lantern Pharma raised?
Lantern Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Lantern Pharma last raise money?
Lantern Pharma's most recent round on record is a Series A, in May 2017.
What does Lantern Pharma do?
Based in Texas, US, and founded in 2013 Lantern Pharma, Inc.
Where is Lantern Pharma headquartered?
Lantern Pharma is headquartered in Dallas, US.
Which VCs invest in companies like Lantern Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lantern Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Lantern Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.